Van Berkom & Associates’s Healthcare Services Group HCSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,793,135
Closed -$44.8M 62
2021
Q3
$44.8M Sell
1,793,135
-158,656
-8% -$4.29M 1.36% 41
2021
Q2
$61.6M Sell
1,951,791
-748,046
-28% -$22.7M 1.69% 37
2021
Q1
$75.7M Sell
2,699,837
-425,874
-14% -$12.9M 1.65% 35
2020
Q4
$87.8M Buy
3,125,711
+188,673
+6% +$4.56M 2.01% 28
2020
Q3
$63.2M Sell
2,937,038
-266,174
-8% -$6.21M 1.83% 31
2020
Q2
$78.4M Sell
3,203,212
-13,364
-0.4% -$316K 2.3% 22
2020
Q1
$76.9M Buy
3,216,576
+758,978
+31% +$19.5M 2.75% 12
2019
Q4
$59.8M Buy
2,457,598
+4,077
+0.2% +$101K 1.61% 36
2019
Q3
$59.6K Buy
2,453,521
+459,748
+23% +$11.6M 1.46% 34
2019
Q2
$60.5M Buy
1,993,773
+380,175
+24% +$12.6M 1.75% 33
2019
Q1
$53.2M Buy
1,613,598
+352,162
+28% +$13.5M 1.69% 37
2018
Q4
$50.7M Buy
1,261,436
+118,770
+10% +$5.02M 1.79% 35
2018
Q3
$46.4M Buy
1,142,666
+850,262
+291% +$35.3M 1.32% 43
2018
Q2
$12.6M Buy
+292,404
New +$11.6M 0.37% 51

Other funds holding HCSG

Van Berkom & Associates's HCSG Position: Q4 2021 in Review

Van Berkom & Associates sold out of Healthcare Services Group (HCSG) in Q4 2021, closing a stake of 1,793,135 shares — an estimated $44.8M sold.

Van Berkom & Associates first reported a position in HCSG in Q2 2018 and held it in 14 quarters. The position peaked at $87.8M in Q4 2020. 224 funds tracked by Wall St. Rank hold HCSG as of Q4 2021.

  • Van Berkom & Associates reported no remaining Healthcare Services Group position as of Q4 2021 after selling out during the quarter.
  • Van Berkom & Associates sold 1,793,135 Healthcare Services Group shares in Q4 2021, an estimated $44.8M.
  • Van Berkom & Associates first reported a position in Healthcare Services Group in Q2 2018 and held it in 14 quarters.
  • Van Berkom & Associates's Healthcare Services Group position peaked at $87.8M in Q4 2020.
  • 224 funds tracked by Wall St. Rank held Healthcare Services Group as of Q4 2021.

Based on Van Berkom & Associates's 13F filing for Q4 2021, filed 2 Feb 2022.